Companies: 10,795·Total market cap: $144.5T
NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation

NMTCNASDAQHealthcare● Active
$3.46
+$0.02(+0.58%)
Market Cap$29824771
P/E Ratio
52W High$6.96
52W Low$3.276
Overview

NeuroOne Medical Technologies Corporation (NMTC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NMTC · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.87nmtc eps ttm · nmtc earnings per shareEarnings history
PE Ratio (TTM)nmtc pe ratio ttm · nmtc price to earningsPE Ratio deep dive
Revenue (TTM)$9.7Mnmtc revenue ttm · nmtc annual revenueFull revenue history
Dividend YieldNo Dividenddoes nmtc pay dividends · nmtc dividend yieldDividend history
Shares Outstanding6.7Mnmtc shares outstanding · nmtc floatShares outstanding history
Next EarningsAug 13, 2026Est.nmtc earnings date · nmtc next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$12.1M▲ +250.35% YoY
202320242025
neuroone medical technologies corporation revenue · nmtc revenue 2025
FY 2025Net Income-$3.6M▲ +70.73% YoY
202320242025
neuroone medical technologies corporation net income · nmtc profit 2025
FY 2025EPS$-0.54▲ +80.43% YoY
202320242025
nmtc eps · neuroone medical technologies corporation earnings per share 2025
TTM:Revenue: $9.7MNet Income: -$6.6MEPS: $-0.87View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy3 analystsis nmtc a buy · nmtc analyst rating
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$3.00Low
$3.46Current
$3.00Avg Target13.29% downside
$3.00High
nmtc price target · nmtc 12 month forecast

Total: 3 · Buy rate: 66.7%

The NMTC analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing -13.29% downside from the current price of $3.46.

Stock Performance

Full History
1D+0.58%
1W+0.58%
1M-27.31%
3M-26.85%
YTD-23.96%
1Y-1.98%
5Y-91.81%

About NeuroOne Medical Technologies Corporation

CEODavid A. Rosa
IPO DateMar 15, 2018
Employees17
CountryUS
Websiten1mtc.com

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode s…

what is neuroone medical technologies corporation · nmtc stock overview · neuroone medical technologies corporation company profile · who is neuroone medical technologies corporation ceo · nmtc NASDAQ · neuroone medical technologies corporation headquarters · neuroone medical technologies corporation business segments

About Stock Overview & Key Data

NeuroOne Medical Technologies Corporation (NMTC) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Mar 15, 2018. As of the latest trading session, NMTC stock price is $3.46, with a market capitalization of $29.8M. The stock has returned -1.98% over the past 12 months and -23.96% year-to-date.

According to 3 Wall Street analysts, the consensus rating for NeuroOne Medical Technologies Corporation stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, NeuroOne Medical Technologies Corporation reported revenue of $12.1M and net income of -$3.6M. For detailed data — including NeuroOne Medical Technologies Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, NeuroOne Medical Technologies Corporation (NMTC) stock price is $3.46. The stock is traded on NASDAQ under the ticker symbol NMTC. The 52-week range is $3.28 – $6.96.

NMTC stock priceNMTC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice